Trial Profile
Impacts of Superselective Infarct-related Artery Infusion of Tirofiban on Myocardial Reperfusion and Bleeding Complications in ST Segment Elevation Myocardial Infarction (STEMI) Patients.
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Tirofiban (Primary)
- Indications Myocardial infarction
- Focus Therapeutic Use
- Acronyms SUIT-AMI
- 02 Sep 2010 New trial record